Arcus Biosciences Inc expected to post a loss of $1.25 a share - Earnings Preview

Arcus Biosciences

21/02/2025 22:24

* Arcus Biosciences Inc  RCUS.N   RCUS.K  is expected
to show a
fall in quarterly revenue when it reports  results on February
25 for the period ending December 31 2024
    * The Hayward California-based  company is expected to
report a
6.8% decrease in revenue to $28.9 million from $31 million a
year ago, according to the mean estimate from 10 analysts, based
on LSEG data.The company's guidance on November 6 2024, for the
period ended December 31, was for revenue of $30.000 million.
    * ​LSEG's mean analyst estimate for Arcus Biosciences Inc is
for a
loss of $1.25 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Arcus
Biosciences
Inc is $29.00​, above​ its last closing price of $11.07. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2024  -1.03       -1.06      -1.00     Beat    5.9
 Jun. 30 2024  -1.12       -1.10      -1.02     Beat    7.1
 Mar. 31 2024  -1.02       -0.95      -0.05     Beat    94.7​
 Dec. 31 2023  -1.00       -1.02      -1.08     Missed  -5.5
 ​​Sep.        -1.12       -1.13      -0.94     Beat    16.7
 30 2023                                                
 Jun. 30 2023  -1.09       -1.10      -1.04     Beat    5.3​
 Mar. 31 2023  -1.17       -1.16      -1.09     Beat    6.3
 Dec. 31 2022  -1.02       -1.07      -0.93     Beat    12.8
 This summary was machine generated February 21 at 22:24 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)